Follow The Filings

ACHC Acadia Healthcare Company In

Health Care, filed as ACADIA HEALTHCARE COMPANY IN (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 4

  • 4 Owners
  • Max 6.0%
  • $397M
  • 1 add 2 reduce 2 exits 1 small

In 2026 Q2, 1 manager added, 2 trimmed, and 2 sold out.

Who owns this now

Largest portfolio weights among holders, up to 6.0% (Abrams Bison, Abrams Bison Investments). Not free-float ownership.

  1. Abrams Bison Reduce 6.0%
  2. David Einhorn Reduce 3.3%
  3. Eric Khrom Reduce 1.6%
  4. Farallon Capital Management Add 0.58%

Who owns ACHC

Sorted by value, long equity only, as of 2026 Q2.

History
David Einhorn, DME Capital Management 3.3% Small trim −2.6% 4,400,641 $130M History
Farallon Capital Management 0.58%, was 0.24% Add +143.0% 4,220,800 $125M History
Abrams Bison, Abrams Bison Investments 6.0% Reduce −4.9% 4,165,000 $123M History
Eric Khrom, Khrom Capital Management 1.6%, was 11.1% Reduce −87.5% 647,006 $19M History
Lee Ainslie, Maverick Capital exited 2026 Q2 Last 2026 Q1 0.35% Exit −0.35% 1,314,116 $31M History
George Soros, Soros Fund Management exited 2026 Q2 Last 2026 Q1 0.01% Exit −0.01% 22,536 $527K History

4 current, 2 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ACHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ACHC insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 16 stock grants and 4 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.93B $3.15B $3.31B
Net income -$0.022B $0.256B -$1.1B
Net margin * -0.7% 8.1% -33.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $596M $577.49M $814.14M
Total non-current assets * $4.76B $5.38B $4.71B
Total assets $5.36B $5.96B $5.53B
Total current liabilities $885.78M $577.92M $525.19M
Total non-current liabilities * $1.59B $2.19B $2.86B
Total equity $2.78B $3.07B $1.95B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $462.34M $129.69M $131.9M
Cash from investing -$397.22M -$736.48M -$556.21M
Cash from financing -$62.7M $583.02M $481.25M
Net change in cash $2.42M -$23.77M $56.94M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf